Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TETRALITE (LiteVax BV)
- Development stage
- Unknown
- Lead developer
- LiteVax
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**TETRALITE** is a novel inactivated seasonal influenza vaccine adjuvanted with LiteVax Adjuvant (LVA), combining a low dose of a licensed influenza vaccine (such as VaxigripTetra at 15 µg) with 0.5 mg or 1 mg LVA to enhance immunogenicity, particularly in older adults. Developed to improve vaccine effectiveness against influenza by inducing stronger immune responses through systems vaccinology approaches evaluating genomic, transcriptomic, proteomic, metabolomic, and lipidomic profiles. It targets seasonal influenza prevention and is under investigation in Phase 1b trials focused on safety, tolerability, and dose-dependent mechanisms in adults aged 60+ compared to younger cohorts.
- Brand names
- TETRALITE
- Other names
- INDIGO adjuvanted seasonal influenza vaccine (EU)LiteVax-Influenza virus-adjuvanted vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on TETRALITE (LiteVax BV).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TETRALITE (LiteVax BV).